Clinical trials

When you seek care at an academic medical center like UK HealthCare, your treatment is backed up by leading-edge discoveries made by our researchers. And you have the opportunity to participate in innovative clinical trials that offer you the latest treatment options.

Current trial titles

11-GYN-098-MCC: A Non-randomized Neoadjuvant Platinum-based Chemotherapy in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Trial Protocol (IRB #11-0903-F3R)

11-GYN-130: Treatment of Endometrial Cancer Utilizing Pathology Intraoperative Consultation to Determine Extent of Surgical Staging (IRB #11-0901-F6A)

GOG-0238: A Randomized Trial Of Pelvic Irradiation With Or Without Concurrent Weekly Cisplatin In Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus (IRB #08-0769-F1V)

GOG-0258: A Randomized Phase III Trial Of Cisplatin And Tumor Volume Directed Irradiation Followed By Carboplatin And Paclitaxel Vs. Carboplatin And Paclitaxel For Optimally Debulked, Advanced Endometrial Carcinoma (IRB #09-0902-F1V)

GOG-0260: A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer (IRB #11-0350-F6A)

GOG-0261: A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Ifosfamide plus Paclitaxel in Chemotherapy- Naive Patients with Newly Diagnosed Stage I-IV Persistent or Recurrent Carcinoma (Mixed Mesodermal Tumors) of the Uterus (IRB #10-0067-F6A)

GOG-0263: Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA, Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphdenectomy (IRB #11-0556-F6A)

GOG-3001 (Trinova-3, Amgen 20101129/ENGOT-ov2): A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers (IRB #13-0274-F1V)

88-GYN-13: Transvaginal Ultrasonography As a Screening Method for Ovarian Cancer


Complete trial information


Protocol No.

11-GYN-098-MCC


Title

11-GYN-098-MCC: A Non-randomized Neoadjuvant Platinum-based Chemotherapy in Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Trial Protocol (IRB #11-0903-F3R)


PI Name

Miller, Rachel, W


Phase

Phase II


Protocol Type

Therapeutic intervention


Summary 4 Type

Agent/Device


Age Group

Adults


Sponsor Type

Institutional


Back to top


Protocol No.

11-GYN-130


Title

11-GYN-130: Treatment of Endometrial Cancer Utilizing Pathology Intraoperative Consultation to Determine Extent of Surgical Staging (IRB #11-0901-F6A


PI Name

Ueland, Frederick


Phase

Phase II


Protocol Type

Therapeutic intervention


Summary 4 Type

Agent/Device


Age Group

Adults


Sponsor Type

Institutional


Back to top


Protocol No.

GOG-0238


Title

GOG-0238: A Randomized Trial Of Pelvic Irradiation With Or Without Concurrent Weekly Cisplatin In Patients With Pelvic-Only Recurrence of Carcinoma of the Uterine Corpus (IRB #08-0769-F1V


PI Name

Ueland, Frederick


Phase

Phase II


Protocol Type

Therapeutic intervention


Summary 4 Type

Agent/Device


Age Group

Adults


Sponsor Type

National group


Back to top


Protocol No.

GOG-0258


Title

GOG-0258: A Randomized Phase III Trial Of Cisplatin And Tumor Volume Directed Irradiation Followed By Carboplatin And Paclitaxel Vs. Carboplatin And Paclitaxel For Optimally Debulked, Advanced Endometrial Carcinoma (IRB #09-0902-F1V)


PI Name

Ueland, Frederick


Phase

Phase III


Protocol Type

Therapeutic intervention


Summary 4 Type

Agent/Device


Age Group

Adults


Sponsor Type

National group


Back to top


Protocol No.

GOG-0260


Title

GOG-0260: A Phase II Evaluation of Elesclomol Sodium and Weekly Paclitaxel in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer (IRB #11-0350-F6A)


PI Name

Ueland, Frederick


Phase

Phase II


Protocol Type

Therapeutic intervention


Summary 4 Type

Agent/Device


Age Group

Adults


Sponsor Type

National group


Back to top


Protocol No.

GOG-0261


Title

GOG-0261: A Randomized Phase III Trial of Paclitaxel plus Carboplatin versus Ifosfamide plus Paclitaxel in Chemotherapy- Naive Patients with Newly Diagnosed Stage I-IV Persistent or Recurrent Carcinoma (Mixed Mesodermal Tumors) of the Uterus (IRB #10-0067-F6A)


PI Name

Ueland, Frederick


Phase

Phase III


Protocol Type

Therapeutic intervention


Summary 4 Type

Agent/Device


Age Group

Adults


Sponsor Type

Institutional


Back to top


Protocol No.

GOG-0263


Title

GOG-0263: Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA, Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphdenectomy (IRB #11-0556-F6A)


PI Name

Ueland, Frederick


Phase

Phase III


Protocol Type

Therapeutic intervention


Summary 4 Type

Agent/Device


Age Group

Adults


Sponsor Type

National group


Back to top


Protocol No.

GOG-3001


Title

GOG-3001 (Trinova-3, Amgen 20101129/ENGOT-ov2): A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers (IRB #13-0274-F1V)


PI Name

Ueland, Frederick


Phase

Phase III


Protocol Type

Therapeutic intervention


Summary 4 Type

Agent/Device


Age Group

Adults


Sponsor Type

National group


Back to top


Protocol No.

88-GYN-13


Title

Transvaginal Ultrasonography As a Screening Method for Ovarian Cancer


PI Name

van Nagell Jr., John


Phase

NA


Protocol Type

Screening, Early Detection or Diagnosis


Summary 4 Type

Other interventions


Age Group

Adults


Sponsor Type

Institutional


Back to top

Page last updated: 8/5/2015 3:14:36 PM